DiRx, Inc.

DiRx, Inc. is a licensed online pharmacy providing FDA-approved generic medications directly to consumers, focusing on affordability and accessibility without requiring insurance. Founded in 2020, DiRx, Inc. operates as a licensed online pharmacy.

The company has not undergone any significant pivots in strategy. Satish Srinivasan serves as both the CEO and the founder. DiRx, Inc. is headquartered in the United States and has completed a total of 3 funding deals, the most recent being on December 28, 2021.

In this round, the company raised USD 5. 75 mn in Series A funding, amounting to the total raised of USD 5. 75 mn. DiRx Health Pharmacy specializes in offering a comprehensive range of FDA-approved generic medications directly to consumers across the United States, including all 50 states and Washington D.

C. The platform prioritizes affordability and ease of access for patients, providing options for both one-time purchases and auto-refill services. This model effectively addresses the high costs associated with prescription drugs, enabling customers to obtain necessary medications at lower prices compared to traditional pharmacies. DiRx Health Pharmacy employs a direct-to-consumer business model, generating revenue primarily from the single transaction sales of generic medicines, which are competitively priced against traditional retail pharmacies.

Customers can place orders using active prescriptions with free shipping available on all generic drugs. This structure allows the company to attract a diverse customer base seeking essential healthcare products without the prerequisite of insurance coverage. Following the Series A funding round on December 28, 2021, DiRx, Inc. plans to utilize the raised USD 5.

75 mn to expand its operations into the international market. The company aims to introduce new products designed to enhance its current offerings, although specific launch dates have not been disclosed. This strategic expansion is anticipated to broaden its reach and accessibility in global healthcare markets.